KLGNX
Price
$50.60
Change
-$3.74 (-6.88%)
Updated
Feb 3 closing price
Net Assets
994.72M
RGEBX
Price
$75.85
Change
-$9.36 (-10.98%)
Updated
Feb 3 closing price
Net Assets
335.97B
Interact to see
Advertisement

KLGNX vs RGEBX

Header iconKLGNX vs RGEBX Comparison
Open Charts KLGNX vs RGEBXBanner chart's image
NYLI WMC Growth Investor Class
Price$50.60
Change-$3.74 (-6.88%)
VolumeN/A
Net Assets994.72M
American Funds Growth Fund of Amer R2E
Price$75.85
Change-$9.36 (-10.98%)
VolumeN/A
Net Assets335.97B
KLGNX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
KLGNX vs. RGEBX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KLGNX is a StrongBuy and RGEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 336B vs. KLGNX (995M). KLGNX (0.00) and RGEBX (0.00) have matching dividends . KLGNX was incepted earlier than RGEBX: KLGNX (13 years) vs RGEBX (11 years). KLGNX (1.41) is less costly to investors than RGEBX (1.08). KLGNX is a more actively managed with annual turnover of: 38.00 vs. RGEBX (32.00). RGEBX has a lower initial minimum investment than KLGNX: RGEBX (250) vs KLGNX (2500). KLGNX annual gain was more profitable for investors over the last year : 5.15 vs. RGEBX (1.80). RGEBX return over 5 years is better than : 9.88 vs. KLGNX (2.97).
KLGNXRGEBXKLGNX / RGEBX
Total Expense Ratio1.321.08122%
Annual Report Gross Expense Ratio1.411.08131%
Fund Existence13 years11 years-
Gain YTD-4.112-1.057389%
Front Load5%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets995M336B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year5.151.80287%
Returns for 3 years59.1741.63142%
Returns for 5 years2.979.8830%
Returns for 10 years103.05110.0294%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SATL4.180.50
+13.59%
Satellogic Inc
EVRG77.801.84
+2.42%
Evergy
BEAM27.89-0.03
-0.11%
Beam Therapeutics
RDHL1.12-0.03
-2.61%
Redhill Biopharma Ltd
CURR1.38-0.07
-4.83%
Currenc Group Inc